HIV infection, viral hepatitis and liver fibrosis among prison inmates in West Africa

• Published in: BMC infectious diseases 2016-06, Vol.16 (1), p.249-249, Article 249
• Main Authors: Jaquet, Antoine, Wandeler, Gilles, Tine, Judicaël, Dagnra, Claver A, Attia, Alain, Patassi, Akouda, Ndiaye, Abdoulaye, de Ledinghen, Victor, Ekouevi, Didier K, Seydi, Moussa, Dabis, François
• Format: Article
• Language: English
• Subjects: Adult; Africa, Western - epidemiology; Alanine Transaminase - blood; Aspartate Aminotransferases - blood; Care and treatment; Coinfection - epidemiology; Comorbidity; Diagnosis; Disease transmission; DNA, Viral - blood; Elasticity Imaging Techniques; Health aspects; Hepatitis B - blood; Hepatitis B - epidemiology; Hepatitis B Surface Antigens - blood; Hepatitis B virus - genetics; Hepatitis C; Hepatitis C - blood; Hepatitis C - epidemiology; Hepatitis C - immunology; Hepatitis C Antibodies - immunology; HIV infection; HIV Infections - epidemiology; Humans; Infectious diseases; Liver - diagnostic imaging; Liver cirrhosis; Liver Cirrhosis - diagnostic imaging; Liver Cirrhosis - epidemiology; Male; Medicine, African Traditional - utilization; Odds Ratio; Prevalence; Prisoners; Prisoners - statistics & numerical data; Risk Factors; Senegal - epidemiology; Severity of Illness Index; Sexually transmitted diseases; Time Factors; Togo - epidemiology; Viral Load; Young Adult
• ISSN: 1471-2334; 1471-2334
• DOI: 10.1186/s12879-016-1601-4

Prisoners represent a vulnerable population for blood-borne and sexually transmitted infections which can potentially lead to liver fibrosis and ultimately cirrhosis. However, little is known about the prevalence of liver fibrosis and associated risk factors among inmates in sub-Saharan Africa. Screening of liver fibrosis was undertaken in a randomly selected sample of male inmates incarcerated in Lome, Togo and in Dakar, Senegal using transient elastography. A liver stiffness measurement ≥9.5 KPa was retained to define the presence of a severe liver fibrosis. All included inmates were also screened for HIV, Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) infection. Substances abuse including alcohol, tobacco and cannabis use were assessed during face-to-face interviews. Odds Ratio (OR) estimates were computed with their 95 % Confidence Interval (CI) to identify factors associated with severe liver fibrosis. Overall, 680 inmates were included with a median age of 30 years [interquartile range: 24-35]. The prevalence of severe fibrosis was 3.1 % (4.9 % in Lome and 1.2 % in Dakar). Infections with HIV, HBV and HCV were identified in 2.6 %, 12.5 % and 0.5 % of inmates, respectively. Factors associated with a severe liver fibrosis were HIV infection (OR = 7.6; CI 1.8-32.1), HBV infection (OR = 4.8; CI 1.8-12.8), HCV infection (OR = 52.6; CI 4.1-673.8), use of traditional medicines (OR = 3.7; CI 1.4-10.1) and being incarcerated in Lome (OR = 3.3; CI 1.1-9.8) compared to Dakar. HIV infection and viral hepatitis infections were identified as important and independent determinants of severe liver fibrosis. While access to active antiviral therapies against HIV and viral hepatitis expands in Africa, adapted strategies for the monitoring of liver disease need to be explored, especially in vulnerable populations such as inmates.